Boehringer's Restless Leg Syndrome Drug To Be Promoted By Neurology/Primary Care Reps
This article was originally published in The Pink Sheet Daily
Executive Summary
Parkinson's agent Mirapex gains supplemental indication, will compete with GSK's Requip.